Employee Benefit News19hOpinion
The major factors that go into the decision to cover GLP-1s
As employers grapple with including GLP-1s in their benefits packages, they face a complex decision that boils down to two ...
Medscape4d
The Glucagonostatic and Insulinotropic Effects of Glucagon-like Peptide 1 Contribute Equally to its Glucose-lowering Action
Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...
From Davids to Goliaths: the GLP-1RA gold rush
There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.
Nature2mon
The next era for GPCR-focused biopharma
Heptares was also first to solve the glucagon-like peptide 1 (GLP-1) receptor structure 7, which could enable the next generation of today’s blockbuster anti-obesity drugs. In 2015, Heptares was ...
Structure Therapeutics (NASDAQ:GPCR) Trading Up 5.6% – What’s Next?
Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) rose 5.6% on Thursday . The company traded as high as $29.87 and last traded at $29.84. Approximately 85,014 shares changed hands during mid ...
EurekAlert!1mon
Current status of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatotic liver disease: A clinical perspective
The global prevalence of MASLD is substantial, with estimates ranging from 30% to 32%, and the incidence of associated conditions like liver fibrosis is expected to rise dramatically in the coming ...
Hosted on MSN1mon
Drugs Like Ozempic May Have a Shrinking Effect on The Heart
Recently, some experts have raised concerns that novel weight loss drugs – known as glucagon-like peptide-1 (GLP-1 ... "We suggest that cardiac structure and function be carefully evaluated ...